Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

PolyMASC announces factor VIII research agreement with Bayer

Aug. 17, 1999

Factor Xa inhibitors from DuPont with potent antithrombotic activity in rabbits

Aug. 12, 1999

Preliminary results of SYMPHONY indicate that Xubix is effective in acute coronary syndromes

Aug. 9, 1999

Teijin prepares factor Xa inhibitor series

Aug. 6, 1999

Health Canada approves Integrilin for marketing

Aug. 6, 1999

Hoechst Marion Roussel reveals new anticoagulants with advantages over heparin

Aug. 4, 1999

Genentech seeks FDA approval for tenecteplase

Aug. 3, 1999

New thrombin inhibitor approved in Italy for antithrombotic prophylaxis

July 29, 1999

Anthranilide anticoagulants developed by Schering AG researchers

July 29, 1999

Antiplatelet agents acting as IP receptor agonists developed at Fujisawa

July 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...